forest laboratories

This weekend in Barron's online: the annual list of the best chief executives in the world, and the prospects for Darden Restaurants, Sarepta Therapeutics and Seacor Holdings. Cover Story "World's Best CEOs" by Andrew Bary. Barron's ninth annual list of the 30 best chief executives in the...

In this morning's Marketwatch alert on companies that may report earnings surprises for the fourth quarter, just three were expected to offer positive surprises. Goldman Sachs (NYSE: GS) was seen beating the consensus estimate by up to 18 percent. Forest Laboratories (NASDAQ: FRX) could turn in a...

The earnings crunch gets underway this week, with big names in the financial, technology, consumer goods and other sectors on tap to share their most recent quarterly results. Among those expected to post the biggest year-over-year gains in earnings are Abbott Labs (NYSE: ABT), BlackRock (NYSE: BLK...

Citadel Securities has published a report on Forest Laboratories (NYSE: FRX) initiating coverage on the medicine developer. In the report, Citadel wrote, "We believe Forest revenue growth from fiscal 2013 to fiscal 2016 will be dependent on successful launches of recently approved drugs Teflaro,...

Forest Laboratories (NYSE: FRX) and Watson Pharmaceuticals (NYSE: WPI) reached new 52-week highs of $40.52 and $66.00 per share, respectively, in Wednesday's trading session. Forest Labs saw an upgrade from Argus and Duncan-Williams upgraded its price target on the stock to $45 in the wake of...

Duncan-Williams, which raised its PT on shares of Forest Laboratories Inc. (NYSE: FRX), is providing some color on the stock. “In a recent SEC filing Forest disclosed that the Icahn parties held 7.20% of the outstanding common stock (fourth largest shareholder behind Wellington, Vanguard, and...

Duncan Williams has raised the price target on Forest Laboratories (NYSE: FRX) from $40 to $45 and maintains its Buy rating.

Colgate-Palmolive (NYSE: CL) and Forest Laboratories (NYSE: FRX) reached new 52-week highs of $89.28 and $39.56 per share, respectively, late in Monday's trading session. Colgate just announced the completion of its purchase of the Sanex personal care brand from Unilever (NYSE: UL). Colgate has a...

According to Goldman Sachs, Forest Laboratories (NYSE: FRX) announced it has received notice that High River Limited Partnership, an entity affiliated with Carl Icahn, has taken a 6.5% stake in the company (options and shares) and intends to nominate four individuals for election to Forest's nine-...

CIGNA (NYSE: CI) and Forest Laboratories (NYSE: FRX) reached new 52-week highs of $50.70 and $37.87 per share, respectively, on Thursday but were lower in premarket trading Friday. CIGNA was raised to Outperform as yesterday's Bull of the Day at Zacks. The company has a market cap of $13.6...